Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.

Open Access

Review articles summarize the best available evidence on a topic relevant to the NTD community.

Eduard E. Zijlstra ,

* E-mail: ezijlstra@dndi.org

Affiliations Drugs for Neglected Diseases initiative, Geneva, Switzerland, Rotterdam Centre for Tropical Medicine, Rotterdam, the Netherlands
⨯
Fabiana Alves,

Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland
⨯
Suman Rijal,

Affiliation Drugs for Neglected Diseases initiative, India Office, New Delhi, India
⨯
Byron Arana,

Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland
⨯
Jorge Alvar

Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland
⨯

Reader Comments (0)

Leishmaniasis
Is the Subject Area "Leishmaniasis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Kala-azar
Is the Subject Area "Kala-azar" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Parasitic diseases
Is the Subject Area "Parasitic diseases" applicable to this article?

Thanks for your feedback.
Bangladesh
Is the Subject Area "Bangladesh" applicable to this article?

Thanks for your feedback.
Sand flies
Is the Subject Area "Sand flies" applicable to this article?

Thanks for your feedback.